Jason M. Pogue, PharmD, BCPS, BCIDP

Pogue is a clinical professor in the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy and an infectious diseases clinical pharmacist at Michigan Medicine.

Articles by Jason M. Pogue, PharmD, BCPS, BCIDP

Further Insights, Treatment Considerations Around the PETERPEN Study

ByJohn Parkinson,Jason M. Pogue, PharmD, BCPS, BCIDP

October 1st 2026

Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.

Carbapenem-Sparing Therapy for ESBL Bacteremia: New Trials, Old Questions

ByRyan K. Shields, PharmD, MS,Jason M. Pogue, PharmD, BCPS, BCIDP

September 24th 2026

New data from the PETERPEN trial suggest that piperacillin-tazobactam may be noninferior to meropenem for early clinical outcomes in select patients with ESBL bloodstream infections, but carbapenems remain the standard of care until final mortality results are available and fully analyzed.

COVID-19 Treatment: Updates March 19-24, 2020

ByErin K. McCreary, PharmD, BCPS, BCIDP*,Jason M. Pogue, PharmD, BCPS, BCIDP

March 26th 2020

Erin K. McCreary, PharmD, BCPS, BCIDP; and Jason M. Pogue, PharmD, BCPS, BCIDP, provide an update of published literature on experimental treatments for COVID-19 from the past week.